(S)-5-(tert-butyldimethylsilyloxy)-1,4,5,6-tetrahydropyridazine | 909730-49-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: (S)-5-(tert-butyldimethylsilyloxy)-1,4,5,6-tetrahydropyridazine
• CAS: 909730-49-0
• 化学式: C₁₀H₂₂N₂OSi
• 分子量: 214.383
• InChiKey: QJFKQRMCMJZXJO-VIFPVBQESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.36
• 重原子数：
  14.0
• 可旋转键数：
  2.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  33.62
• 氢给体数：
  1.0
• 氢受体数：
  3.0

反应信息

• 作为反应物：
  描述：

  (S)-5-(tert-butyldimethylsilyloxy)-1,4,5,6-tetrahydropyridazine 在 吡啶 、 magnesium acetate 、 溶剂黄146 作用下， 反应 17.0h， 生成 (3S,5S)-1-benzoyl-5-(tert-butyldimethylsilyloxy)-hexahydropyridazine-3-carbonitrile
  参考文献：
  名称：

  The efficient synthesis of (3R,5R)-5-hydroxypiperazic acid and its diastereomer using Lewis acid-promoted diastereoselective Strecker synthesis

  摘要：

  The stereoselective synthesis of (3R,5R)-5-hydroxypiperazic acid, a component of naturally occurring antibiotic cyclodepsipeptides, and its diastereomer was achieved via the use of Lewis acid-promoted diastereoselective Strecker synthesis as a key step, in which an interesting stereochemical reversal of diastereoselectivity by the choice of Lewis acid catalyst was observed. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2006.06.004
• 作为产物：
  描述：

  ethyl (S)-4-chloro-3-(tert-butyldimethylsilyloxyl)butanoate 在 肼 作用下， 以 乙醇 为溶剂， 反应 0.33h， 生成 (S)-5-(tert-butyldimethylsilyloxy)-1,4,5,6-tetrahydropyridazine
  参考文献：
  名称：

  Progress toward the synthesis of piperazimycin A: exploration of the synthesis of γ-hydroxy and γ-chloropiperazic acids

  摘要：

  Employing Hamada's chemistry with MAOS optimization of several steps, an expedient route to key (3S,5S)- and (3R,5R)-gamma-hydroxy and (3R,5S)-gamma-chloropiperazic acids, was developed en route to a total synthesis of piperazimycin A. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2008.04.132